Clinical trial
A Multicenter, Open, Comparative Study on the Effect of Palomacare® Vaginal Gel on Vaginal Dysbiosis in Premenopausal Women (DISPALOMA)
NCT06668012 is registered in ClinicalTrials.gov with Procare Health Iberia S.L. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Open, Comparative Study on the Effect of Palomacare® Vaginal Gel on Vaginal Dysbiosis in Premenopausal Women (DISPALOMA)
- Lead sponsor
- Procare Health Iberia S.L.
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- December 12, 2024
- Completion date
- May 31, 2025
- Enrollment
- 30 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
vaginal dysbiosis